Electron Optics Development Co., LLC
Harvard Medical School - Breast Cancer Research
Home
Partnerships & Technologies available for license
Cancer research at Harvard
Rapid Fire Device for Ballistic Missile Defense
Deactivation of buried electronics
Cancer research papers
Press coverage
About us
Contact Us
Since 1998, Michael Retsky has been part time Lecturer in Surgery in the late Judah Folkman's Department of Vascular Biology at Children's Hospital and Harvard Medical School. A series of papers has been published in the past few years with coauthors Romano Demicheli, M.D., Ph.D., William Hrushesky, M.D., Michael Baum, M.D., Isaac Gukas M.D., Ph.D. and (on one paper) Dr. Folkman on a revolutionary hypothesis for breast cancer growth and development.

hrushesky.jpg
William Hrushesky

mike-romano-nice-2004.jpg
Romano Demicheli and Michael Retsky. Picture was taken in Nice, France 2004

baum-gukas-retsky-london-aug-2006.jpg
Michael Baum, Isaac Gukas and Michael Retsky in London August 2006

RESEARCH HIGHLIGHTS OF 2004
Two papers published by Breast-Cancer-Research were downloaded over 25,000 times. One was subject of a press release by BCR.
Biomedcentral Press Release:
RESEARCH HIGHLIGHTS OF 2005
A paper published by International Journal of Surgery was the subject of press releases by IJS and Harvard Medical School. The paper was also the subject of a 1200 word write-up in Wall Street Journal by Pulitzer Prize winning reporter Amy Marcus.
Ascend Foundation:
Children's Hospital Boston:
RESEARCH HIGHLIGHTS OF 2006
This research proposes a new explanation for the racial differences in breast cancer outcome.  See Retsky et al. International Journal of Surgery, 2007, 5:300-3004.
RESEARCH HIGHLIGHTS OF 2007
A new method of treatment for early stage breast cancer was proposed and published (Patent pending).

RESEARCH HIGHLIGHTS OF 2008
Support builds for our observations on bimodal relapse patterns and theory that dormancy is common in breast cancer. Our theory that the first relapse peak is iatrogenic is becoming more accepted.
RESEARCH HIGHLIGHT OF 2009
Paper published describing Dr. Retsky's first use of a
low dose and long term continuous infusion therapy for
early stage colon cancer. This therapy is now called metronomic chemotherapy and Dr. Retsky's treatment
played a key role in this development. See Retsky 2009.
RESEARCH HIGHLIGHT OF 2010
Dr. Retsky now at Harvard School of Public Health is co-PI of a $600k 3-year grant from Komen Foundation.